The global peripheral vascular devices market, valued at USD 4.7 billion in 2022, is projected to expand at a robust CAGR of 6.6%, reaching USD 8.9 billion by 2032, according to Future Market Insights ...

We value keeping the Device Guide up to date.

We value keeping the Device Guide up to date.

R3 Vascular announced that a doctor treated the first patient in the ELITE-BTK pivotal trial of its drug-eluting ...

This was an exciting time in cardiology, as it meant some patients could avoid having open-heart surgery. But it very much ...

A US pharma company has developed an experimental drug that reduces lipoprotein(a) cholesterol by 94% with a single injection ...

The initial long-term results from EFEMORAL I were presented today by Principal Investigator Prof. Andrew Holden (Auckland ...

Parkview Health announced today that its Heart Institute has been selected by medical technology firm Medtronic as one of 65 ...